Evidence map›Paper›PMID 39305217›Full record

ArticleJournal of biomaterials applications2025

Enhancing alginate dialdehyde-gelatin (ADA-GEL) based hydrogels for biofabrication by addition of phytotherapeutics and mesoporous bioactive glass nanoparticles (MBGNs).

Faina Bider, Chiara Gunnella, Jana T Reh, Corina-Elena Clejanu, Sonja Kuth, Ana M Beltrán, Aldo R Boccaccini

Abstract read
In one paragraph

Article in Journal of biomaterials applications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Faina BiderInstitute of Biomaterials, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.ORCID 0000-0002-5898-4802
Chiara GunnellaInstitute of Biomaterials, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.
Jana T RehInstitute of Biomaterials, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.
Corina-Elena ClejanuInstitute of Biomaterials, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.
Sonja KuthInstitute of Biomaterials, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.
Ana M BeltránDepartamento de Ingeniería y Ciencia de los Materiales y del Transporte. Escuela Politécnica Superior, Virgen de África 7, Universidad de Sevilla, Seville (Spain).
Aldo R BoccacciniInstitute of Biomaterials, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.ORCID 0000-0002-7377-2955

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study explores the 3D printing of alginate dialdehyde-gelatin (ADA-GEL) inks incorporating phytotherapeutic agents, such as ferulic acid (FA), and silicate mesoporous bioactive glass nanoparticles (MBGNs) at two different concentrations. 3D scaffolds with bioactive properties suitable for bone tissue engineering (TE) were obtained. The degradation and swelling behaviour of films and 3D printed scaffolds indicated an accelerated trend with increasing MBGN content, while FA appeared to stabilize the samples. Determination of the degree of crosslinking validated the increased stability of hydrogels due to the addition of FA and 0.1% (w/v) MBGNs. The incorporation of MBGNs not only improved the effective moduli and conferred bioactive properties through the formation of hydroxyapatite (HAp) on the surface of ADA-GEL-based samples but also enhanced VEGF-A expression of MC3T3-E1 cells. The beneficial impact of FA and low concentrations of MBGNs in ADA-GEL-based inks for 3D (bio)printing applications was corroborated through various printing experiments, resulting in higher printing resolution, as also confirmed by rheological measurements. Cytocompatibility investigations revealed enhanced MC3T3-E1 cell activity and viability. Furthermore, the presence of mineral phases, as confirmed by an in vitro biomineralization assay, and increased ALP activity after 21 days, attributed to the addition of FA and MBGNs, were demonstrated. Considering the acquired structural and biological properties, along with efficient drug delivery capability, enhanced biological activity, and improved 3D printability, the newly developed inks exhibit promising potential for biofabrication and bone TE.

Indexed as

AlginatesGelatinGlassHydrogelsNanoparticlesPrinting, Three-DimensionalTissue EngineeringTissue ScaffoldsAnimalsBiocompatible MaterialsCell LineCell SurvivalCoumaric AcidsMicePorosityAlginatesBiocompatible MaterialsCoumaric Acidsferulic acidGelatinHydrogels3D (bio)printingbioactive glass particlesbone tissue engineeringdrug deliveryHydrogelsphytotherapeutic agent

Identifiers

PMID39305217
PMCPMC11707976

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.